Our brand is specifically designed to support individuals at every stage of their weight loss journey. This includes those interested in losing weight, as well as individuals currently on GLP-1 (glucagon-like peptide-1) medications or transitioning off them.
GLP-1s have gained prominence as effective weight loss medications. These drugs, such as Ozempic, Wegovy, and Mounjaro, work by mimicking the effects of the hormone GLP-1, which regulates appetite and glucose metabolism. Users often experience reduced cravings and a quieter mind—less of what they refer to as “food noise”—after starting GLP-1 medications.
While there are plenty of solutions available for those interested in weight loss and an increasing variety of food options for GLP-1 users, there’s a noticeable gap in food and beverage support for individuals coming off these medications. When GLP-1 users discontinue their medication, they face a transition period. Suddenly, the drug’s appetite-suppressing effects diminish, and they must navigate their food choices without that support. This transition can be challenging, as the “food noise” returns—those intrusive thoughts about what to eat, how to satisfy cravings, and constant preoccupation with food.
Unfortunately, 66% of the weight lost is regained within 12 months of stopping the medication. We are thus looking for effective dietary solutions that help consumers maintain their weight loss progress whether achieved with or without medication.
We’re actively searching for novel and natural ingredient solutions that can reduce “food noise” and effectively suppress appetite, similar to the effect of anti-obesity medications (drugs), such as GLP-1s and GIPs. Our ideal solution should not only curb “food noise” with high efficacy, but also be adaptable to our existing supply chain, cost-effective, and suitable for implementation within the frozen food, beverage, and snacking categories.
The Q&A is now closed.